(Q33996980)

30 July 2017

Recombinant vaccinia viruses. Design, generation, and isolation (English)

1 reference

30 July 2017

Broder CC

1

1 reference

30 July 2017

Earl PL

series ordinal

2

1 reference

30 July 2017

language of work or name

1 reference

1 December 1999

1 reference

30 July 2017

Molecular Biotechnology

1 reference

30 July 2017

13

1 reference

30 July 2017

3

1 reference

30 July 2017

223-245

1 reference

https://scigraph.springernature.com/pub.10.1385/mb:13:3:223

30 July 2017

0 references

cites work

A PCR-based method for manipulation of the vaccinia virus genome that eliminates the need for cloning

1 reference

12 December 2020

Construction of chimeric vaccinia viruses by molecular cloning and packaging

1 reference

12 December 2020

Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection

1 reference

12 December 2020

A dominant selectable marker for the construction of recombinant poxviruses

1 reference

12 December 2020

Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized wit

1 reference

12 December 2020

Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs

1 reference

12 December 2020

Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection

1 reference

12 December 2020

An infectious clone of human parainfluenza virus type 3

1 reference

12 December 2020

Attenuated poxvirus vectors as carriers in vaccines against human T cell leukemia-lymphoma virus type I.

1 reference

12 December 2020

Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development.

1 reference

12 December 2020

The hygromycin-resistance-eneoding gene as a selection marker for vaccinia virus recombinants

1 reference

12 December 2020

Vaccinia virus: a selectable eukaryotic cloning and expression vector

1 reference

12 December 2020

General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

1 reference

12 December 2020

E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses

1 reference

12 December 2020

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

12 December 2020

Inducible gene expression from vaccinia virus vectors

1 reference

12 December 2020

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

1 reference

12 December 2020

Isolation and handling of recombinant vaccinia viruses

1 reference

12 December 2020

Poxviruses as expression vectors

1 reference

12 December 2020

Vaccinia virus: a tool for research and vaccine development

1 reference

12 December 2020

Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence

1 reference

12 December 2020

Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells

1 reference

12 December 2020

Regulated expression of nuclear genes by T3 RNA polymerase and lac repressor, using recombinant vaccinia virus vectors

1 reference

12 December 2020

Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.

1 reference

12 December 2020

A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts

1 reference

12 December 2020

Poxvirus vectors: cytoplasmic expression of transferred genes

1 reference

12 December 2020

Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants

1 reference

12 December 2020

Applications of pox virus vectors to vaccination: an update

1 reference

12 December 2020

Compact, synthetic, vaccinia virus early/late promoter for protein expression.

1 reference

12 December 2020

Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression

1 reference

12 December 2020

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

1 reference

12 December 2020

New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins

1 reference

12 December 2020

SP6 RNA polymerase containing vaccinia virus for rapid expression of cloned genes in tissue culture

1 reference

12 December 2020

Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor

1 reference

12 December 2020

A modified method for isolation of recombinant vaccinia virus.

1 reference

12 December 2020

The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s)

1 reference

12 December 2020

Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques.

1 reference

12 December 2020

A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages

1 reference

12 December 2020

Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids

1 reference

12 December 2020

Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: recombination-independent selectable cloning vectors

1 reference

12 December 2020

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

1 reference

12 December 2020

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

1 reference

12 December 2020

Transient dominant selection of recombinant vaccinia viruses.

1 reference

12 December 2020

Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences

1 reference

12 December 2020

Vaccinia virus serves as an efficient vector for expressing heterologous proteins in human NTera 2 neurons

1 reference

12 December 2020

Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes

1 reference

12 December 2020

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

1 reference

12 December 2020

Requirements for optimal expression of secreted and nonsecreted recombinant proteins in vaccinia virus systems

1 reference

12 December 2020

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

12 December 2020

Vaccinia virus vectors for gene expression

1 reference

12 December 2020

Inducer-dependent conditional-lethal mutant animal viruses

1 reference

12 December 2020

Expression of polyomavirus virion proteins by a vaccinia virus vector: association of VP1 and VP2 with the nuclear framework

1 reference

12 December 2020

A Comparison of Regulatory Features in Primate Lentiviruses

1 reference

12 December 2020

Dominant host range selection of vaccinia recombinants by rescue of an essential gene

1 reference

12 December 2020

CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.

1 reference

12 December 2020

Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.

1 reference

12 December 2020

Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses

1 reference

12 December 2020

CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy

1 reference

12 December 2020

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1 reference

12 December 2020

Mucosal vaccination with recombinant poxvirus vaccines protects ferrets against symptomatic CDV infection

1 reference

12 December 2020

Construction and characterization of vaccinia direct ligation vectors

1 reference

12 December 2020

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

12 December 2020

Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes

1 reference

12 December 2020

Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages

1 reference

12 December 2020

Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors

1 reference

12 December 2020

Recombinant protein synthesis in Chinese hamster ovary cells using a vaccinia virus/bacteriophage T7 hybrid expression system

1 reference

12 December 2020

Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.

1 reference

12 December 2020

Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases.

1 reference

12 December 2020

Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus

1 reference

12 December 2020

Manipulation of vaccinia virus vectors

1 reference

12 December 2020

Rescue of measles virus using a replication-deficient vaccinia-T7 vector

1 reference

12 December 2020

Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes

1 reference

12 December 2020

Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue

1 reference

12 December 2020

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

1 reference

12 December 2020

Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells

1 reference

12 December 2020

Cloning and expression of foreign genes in vaccinia virus, using a host range selection system

1 reference

12 December 2020

Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors

1 reference

12 December 2020

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

12 December 2020

Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus

1 reference

12 December 2020

Selection of recombinant vaccinia viruses on the basis of plaque formation

1 reference

12 December 2020

Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line

1 reference

12 December 2020

Successful pseudorabies vaccination in maternally immune piglets using recombinant vaccinia virus vaccines

1 reference

12 December 2020

Transfer of the inducible lac repressor/operator system from Escherichia coli to a vaccinia virus expression vector

1 reference

12 December 2020

Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants

1 reference

12 December 2020

Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

1 reference

12 December 2020

Identifiers

DOI

10.1385/MB:13:3:223

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference